Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-jellyfish toxin nanobody ky031, preparation method and use

A nanobody, anti-jellyfish technology, used in the preparation of jellyfish antitoxic preparations, treatment or prevention of jellyfish stings, nanobody KY031, and its preparation field, can solve the problems of jellyfish stings treatment and prevention, etc., and achieve excellent prevention or prevention. Therapeutic effect, the realization of industrialized production, the effect of broad clinical application prospects

Active Publication Date: 2022-07-01
THE NAVAL MEDICAL UNIV OF PLA
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] There are currently no treatments and preventive medicines for jellyfish stings
However, there are no relevant reports on nanobodies against jellyfish stings

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-jellyfish toxin nanobody ky031, preparation method and use
  • Anti-jellyfish toxin nanobody ky031, preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1. Construction of Nanobody Library

[0037] (1) 0.5 mg of jellyfish toxin CfTX1 [Brinkman D, Burnell J. Partial purification of cytolytic venomproteins from the boxjellyfish, Chironex fleckeri [J]. Toxicon, 2008, 51(5): 853-863.] was equal volume with Freund's adjuvant Mix and immunize a Xinjiang Bactrian camel once a week for a total of 6 consecutive immunizations. During the immunization process, B cells are stimulated to express specific nanobodies;

[0038] (2) After 6 immunizations, extract 200 mL of camel peripheral blood lymphocytes and extract total RNA;

[0039] (3) Synthesize cDNA and amplify VHH by nested PCR

[0040] (4) 20 μg pMECS phage display vector and 10 μg VHH were digested with restriction endonucleases Pst1 and NotI, and the two fragments were ligated;

[0041] (5) Transform the ligation product into the electrotransformation competent cell TG1, construct a phage display library and measure the storage capacity, the size of the storage ca...

Embodiment 2

[0042] Example 2. Nanobody screening process

[0043] (1) Take 200 μL of recombinant TG1 cells to culture in 2TY medium, add 50 μL of helper phage VCSM13 to infect TG1 cells during the period, and culture overnight to amplify the phage, use PEG / NaCl to precipitate the phage the next day, and collect the amplified phage by centrifugation;

[0044] (2) will be dissolved in 150mmol / L pH 8.2NaHCO 3 150 μg of jellyfish toxin was coupled to the ELISA plate, placed at 4°C overnight, and a negative control was established at the same time;

[0045] (3) The next day, 100 μL of 5% BSA was added, and it was blocked at room temperature for 2 hours;

[0046] (4) After 2h, add 100 μL of amplified phage (1×10 11 tfu-immunized camel nanobody phage display gene library) for 1 hour at room temperature;

[0047] (5) Wash five times with PBS+0.05% Tween 20 to wash off bound phage;

[0048] (6) Dissociate the specifically bound phage with trypsin with a final concentration of 25 mg / mL, and inf...

Embodiment 3

[0049] Example 3. Screening of specific positive clones by phage-enzyme-linked immunosorbent assay (ELISA)

[0050] (1) Select 200 single colonies from the cell culture plates after the above 3 rounds of screening and inoculate them in 96 deep-well plates containing 100 μg / mL ampicillin TB medium, and set up a blank control, and cultivate to log phase at 37°C After that, IPTG with a final concentration of 1 mmol / L was added and incubated at 28°C overnight;

[0051] (2) Utilize osmotic burst method to obtain crudely extracted antibody, and transfer the antibody to an ELISA plate coated with antigen, and place it at room temperature for 1 h;

[0052] (3) Wash off the unbound antibody with PBST, add 100 μL of Mouse anti-HA tagantibody (mouse anti-HA antibody, purchased from Covance) diluted 1:2000, and place at room temperature for 1 h;

[0053] (4) Wash off the unbound antibody with PBST, add 100 μL of Anti-mousealkaline phosphatase conjugate (goat anti-mouse alkaline phosphata...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of biomedicine, and provides a nanobody KY031 against jellyfish toxin, a preparation method and application. The nanobody is a VHH antibody and has the amino acid sequence shown in SEQ ID NO. 1. The present invention is analyzed by affinity The nanobody has good affinity. It has been proved by small animal experiments that the mice in the antibody protection group pre-injected with the nanobody of the present invention have no symptoms of poisoning after the injection of jellyfish toxin, and no toxin fatality has been observed for one month. The nanobody of the present invention has excellent anti-jellyfish toxin effect, has excellent preventive or therapeutic effect on jellyfish stings, and has broad clinical application prospects.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to a nanobody KY031, a preparation method and uses thereof, especially the use in the preparation of jellyfish antitoxic preparations and in the treatment or prevention of jellyfish stings. Background technique [0002] Jellyfish is an important plankton in the aquatic environment. It is one of the oldest and mysterious creatures in the world. It has existed on the earth about 650 million years ago and is distributed in almost all sea areas. In terms of taxonomy, it includes cnidaria jellyfish, cruciate jellyfish, and cubic jellyfish; in terms of number, the number of jellyfish has exploded in recent decades, which not only leads to the destruction of marine ecosystems, but also causes catastrophic damage to marine fisheries. damage, and the increasing number of jellyfish stings, with thousands of people injured every year, has become a very difficult problem. [00...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/18C12N15/13C12N15/70A61K39/395A61P39/02
CPCC07K16/18C12N15/70A61P39/02C07K2317/569C07K2317/92C07K2317/22C07K2317/76A61K2039/505
Inventor 胡适雷长海
Owner THE NAVAL MEDICAL UNIV OF PLA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com